Consumer Protection

Deliberate Oversight

How bad drugs and devices get to consumers. by Leah Rush Easterby, Contributing Editor June 22, 2021 Biogen Inc.’s stock price soared this month when FDA approved its new Alzheimer’s drug, Aduhelm (aducanumab), through accelerated approval. While most Alzheimer’s treatments address only dementia symptoms, Aduhelm is the first one marketed to treat the disease process […]

The Jones Day Firm Data Breach

Article Provided by Ron Bush Ron Bush Consulting, Inc. 2020 was the year that was.  Was what?  It started off with a bang before the Coronavirus and COVID-19 became household words.  Marriott’s breach of 5.2 million compromised guest accounts and Twitter’s breach compromised accounts of Barack Obama, Jeff Bezos, and the like.  It ended with […]

Walden v. The Bank of New York Mellon Corporation and BNY Mellon, N.A., Case No. 2:20-cv-01972 USDC (E.D. Pa.)

BANK of NEW YORK and MELLON BANK “Private Wealth Client” Fiduciary Breaches Join Feb 16, 2021″LegalCast” with lead counsel from DICELLO LEVITT GUTZLER LLC and COUNCILL GUNNEMAN. Register here: ____________________ The case is Walden v. The Bank of New York Mellon Corporation and BNY Mellon, N.A., Case No. 2:20-cv-01972-CRE in the United States District Court for the Western District […]